Jun 11, 2020
Liminal BioSciences to Present at Raymond James Human Health Innovation Conference
Jun 09, 2020
Liminal Announces Voting Results of Its 2020 Annual And Special General Meeting Of Shareholders (AGM)
May 28, 2020
Liminal BioSciences to present at Jefferies Virtual Healthcare Conference
May 13, 2020
Liminal Biosciences Reports Q1 2020 Results
Mar 22, 2020
Liminal BioSciences comments on Coronavirus (COVID-19)
Mar 20, 2020
Liminal Biosciences Reports Fourth Quarter and 2019 Year End Results
Mar 20, 2020
Liminal BioSciences to report its fourth quarter and year-end 2019 financial results and hold conference call/webcast
Feb 12, 2020
Liminal BioSciences Announces Scientific Presentations at Upcoming Keystone Symposia
Feb 06, 2020
Liminal BioSciences announces upcoming investor presentation at BIO CEO & Investor Conference
Jan 13, 2020
Liminal BioSciences Outlines Corporate Priorities for 2020
Dec 23, 2019
Liminal BioSciences Comments on Unusual Market Activity
Nov 28, 2019
AMF Concludes its Review of the Refinancing Transactions Completed by Liminal BioSciences in April 2019
Nov 27, 2019
Liminal BioSciences to Present at Piper Jaffray Healthcare Conference
Nov 18, 2019
Liminal Presents New Preclinical Data on PBI-4050 and its Effect on Angio-Proliferative Pulmonary Arterial Hypertension
Nov 18, 2019
Liminal BioSciences to Present at the Jefferies 2019 London Healthcare Conference
Nov 18, 2019
Liminal Biosciences announces effectiveness of Registration Statement on Form F-10 and filing of Prospectus Supplement
Nov 15, 2019
Liminal BioSciences to Commence Trading Common Shares on NASDAQ